Abingdon Health's contract research and manufacturing segment focuses on providing comprehensive services for the development and production of lateral flow assays. This includes product development, regulatory support, and technology transfer. The company serves a diverse range of industries, including clinical diagnostics, animal health, plant health, and environmental testing. Their expertise covers assay design, optimization, and scale-up manufacturing, ensuring high-quality and reliable lateral flow tests. Abingdon Health leverages its experience to assist clients in navigating the complexities of regulatory compliance and market access, offering a streamlined path from concept to commercialization. The company's capabilities extend to both established and novel applications of lateral flow technology, positioning them as a key partner for organizations seeking to innovate in rapid diagnostics.

Abingdon Health's product sales segment encompasses the commercialization of its own branded diagnostic products, including the Seralite FLC assay and various rapid tests. This segment focuses on developing and marketing innovative diagnostic solutions that address unmet clinical needs. The company's product development pipeline includes tests for infectious diseases, autoimmune disorders, and other conditions. Abingdon Health leverages its expertise in lateral flow technology to create user-friendly and cost-effective diagnostic tools. The company's commercial strategy involves direct sales, distribution partnerships, and collaborations with healthcare providers. By offering a range of high-quality diagnostic products, Abingdon Health aims to improve patient outcomes and contribute to the advancement of precision medicine.